Detail of the clinical trial

Title of the trial Randomized, open-label, parallel-group, multi-centre phase II/III clinical trial of active cellular immunotherapy with preparation DCVAC/PCa in patients with castrate-resistant prostate cancer
EudraCT number 2011-004735-32
Protocol number SP001
Sponsor SOTIO a.s., Jankovcova 1518/2, Praha 7 - Holešovice 170 00 ČR
Indications Oncology
Diagnosis in patients with castrate-resistant prostate cancer
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Patients
Year of receiving the request to Institute (SÚKL) 2011
Date of approval by Institute (SÚKL) 28.12.2011
Date of approval by EC 11.1.2012
Date of initiation CT in ČR 24.2.2012 (5.3.2012)
Date of ending CT in ČR 26.4.2017 (20.2./2017)
Notice
Sites FN Motol, Komplexní onkologické centrum FN v Motole, V Úvalu 84, Praha 5 150 06-koordinující centrum

‹‹ Back to list